Basedon these previous studies and their own data [18], Choi andBosetti propose the intriguing hypothesis that the potential protective effectsof NSAIDs in AD may be related to COX-1, but not COX-2 inhibition. This evidence concerns the gene PTGS1 and Alzheimer disease.